RTI Biologics buys Pioneer Surgical for $130mm
Executive Summary
RTI Biologics Inc. (orthopedic and biologic implants) is acquiring private implant developer Pioneer Surgical Technology Inc. for $130mm in cash, which will be funded through a five-year $80mm senior secured facility and a $50mm private placement of RTI's convertible preferred shares from Water Street Healthcare Partners.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Intra-Biotech Deal
- Payment Includes Cash for Equity
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice